Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study

V Rickerts1, H Brodt, S Staszewski

  • 1Klinikum der J.W. Goethe Universität Frankfurt, Med. Klinik III / Infektiologie, Theodor-Stern-Kai 7, D-60590 Frankfurt, Germany. Rickerts@em.uni-frankfurt.de

Insights

The incidence of myocardial infarctions (MI) in HIV patients increased after the introduction of highly active antiretroviral therapy (HAART). Age over 40 and prior HAART use were significant risk factors for MI.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • HIV infection is a growing global health concern.
  • Antiretroviral therapies have significantly improved outcomes for HIV patients.
  • Potential cardiovascular complications of HIV treatment require investigation.

Purpose of the Study:

  • To determine if highly active antiretroviral therapy (HAART) is linked to a higher rate of myocardial infarctions (MI) in individuals with HIV.
  • To analyze trends in MI incidence over different treatment eras.

Main Methods:

  • Retrospective cohort study of 4993 HIV-infected patients from 1983-1998.
  • Comparison of MI incidence across four distinct antiretroviral treatment periods.
  • Univariate and multiple regression analyses to identify MI risk factors.

Main Results:

  • A significant increase in MI incidence was observed, rising from 0.86 to 3.41 per 1000 patient-years from 1983-1998 (p=0.002).
  • Factors associated with MI included age >40, prior HAART use, homosexual/bisexual HIV transmission, and prior AIDS diagnosis.
  • Age >40 and previous HAART therapy remained significant predictors in multivariate analysis.

Conclusions:

  • The introduction of HAART in this HIV-infected cohort was associated with an increased incidence of myocardial infarctions.
  • This suggests a potential link between modern antiretroviral treatment regimens and cardiovascular risk in HIV patients.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...